2018
DOI: 10.1016/j.hpb.2018.06.296
|View full text |Cite
|
Sign up to set email alerts
|

Impact of SS18l1 polymorphism in predicting prognosis of hepatocellular carcinoma

Abstract: Introduction: Efficacy of hepatic resection for hepatocellular carcinoma (HCC) is limited by the high incidence of intrahepatic recurrence, which is related to intrahepatic tumor metastasis in early postoperative period. Method: This study aims to develop and test a prediction model for early intrahepatic recurrence after curative hepatic resection for HCC. From 1989 to 2014, 1411 patients with HCC underwent curative hepatic resection. They were divided into development group (n = 706) and validation

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles